Taking all quarters into account it shows there has been minor...

Taking all quarters into account it shows there has been minor traction in uptake of recell very dissapointing another reason for the lastest fall in share price,although they state 88% looks good but still from a low unit base even taking out breathe assist revenue AVH has gone nowhere in a so called big year for AVH,with sales costs up 24% and R+D up 700% sales should be tracking at a way higher rate.
30june 11 sales $878 000
30sept 11 sales $819 000
31 dec 11 sales $830 000
31 mar 12 sales $507 000
31june 12 sales $776 000
AVH constantly brings out selected figures for the investor who cant be bothered to look into its financials but only reads the first page
IMO during the quarter the hypers take over and pump the story then the qrt comes out and the sell off begins because the firgures arnt there to support the hype.
I continue to believe in the story got in at 11c sold most at 23c and will buy more shortly to get ready for the FDA pump.Good luck to all